EZH2 and hepatocellular carcinoma: By providing the first link between oncogenic lncRNAs and chromatin-modifying complexes, and in particular EZH2, in HCC, this study not only uncovered a novel HCC biomarker but also opened the door to the exploration of lncRNA functions in hepatocarcinogenesis.